Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1 for 1₹2.7 LAccepted-Finance 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | ₹2.7 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| 2 | L1 for 1₹3.9 LAccepted-Finance | ₹3.9 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| 3 | L1 for 4₹6.7 LAccepted-Finance | ₹6.7 L | L1 for 4 | Accepted-Finance Being L1 for 04 items. Pl refer attached comparative statement |
| 4 | L1 for 1₹10 LAccepted-Finance | ₹10 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| 5 | L1 for 1₹13.2 LAccepted-Finance | ₹13.2 L | L1 for 1 | Accepted-Finance Being L1 for 01 item. Pl refer attached comparative statement |
| Sl No | Description | Qty | Unit | Roche Products India Pvt Ltd L19 | THERDOSE PHARMA PVT LTD L15 | Intas Pharmaceuticals Ltd. L34 | Dr.Reddys LAboratories Limited L22 | MSD Pharmaceuticals Private Limited L10 | Reliance Life Sciences Private Limited L30 | Johnson and Johnson Private Limited L12 | AstraZeneca Pharma India Limited L5 | Fresenius Kabi Oncology Limited L27 | NEON LABORATORIES LIMITED L24 | Novartis Health Care Private Limited L7 | Eli Lilly And Company India Pvt Ltd L3 | Khandelwal Laboratories Pvt. Ltd. L21 | Hetero Healthcare limited L29 | Cipla Ltd L9 | Merck Specialities Pvt Ltd L13 | GLS PHARMA LTD. L26 | Samarth Life Sciences Pvt. Ltd. L25 | MSN Laboratories Private Limited L18 | Beta Drugs Limited L32 | Getwell Pharma India Private Limited L14 | Shilpa Medicare Limited L6 | Biocon Biologics Limited L1 | M/s Adley Formulation Private Limited L16 | United Biotech (P) Ltd L23 | Pfizer Products India Pvt. Ltd. L4 | NATCO PHARMA LIMITED L28 | BHARAT SERUMS AND VACCINES LIMITED L8 | EMCURE PHARMACEUTICALS LIMITED L2 | BRUCK PHARMA PVT LTD L20 | Bristol-Myers Squibb India Private Limited L11 | Medicamen Biotech Limited L17 | Zydus Lifesciences Limited L31 | BDR Pharmaceuticals International Pvt. Ltd. L33 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | ABIRATERONE TAB IP, 250 mg | 1 | 1 no | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.49 ₹1.4 Cr | - | - | - | 25.2 ₹1.7 Cr | 35 ₹2.4 Cr | 22.38 ₹1.5 Cr | - | - | - | - | - | - | - | - | - | 27 ₹1.8 Cr | - | 24.3 ₹1.6 Cr | - | 22.5 ₹1.5 Cr |
| 2.00 | ACTINOMYCIN D INJ, 0.5mg/3ml | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 3.00 | AMIFOSTINE FOR INJ USP, 500mg | 1 | Vial | - | 1,440 ₹2.6 L | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 4.00 | ANASTRAZOLE TAB IP, 1mg | 1 | 1 No | - | - | - | - | - | - | - | - | - | 3.65 ₹1.7 L | - | - | - | 1.17 ₹53,710 | - | - | - | 1.8 ₹82,820 | - | - | - | - | - | - | - | - | 7.2 ₹3.3 L | - | - | - | - | - | 1.4 ₹64,370 | - |
| 5.00 | ARSENIC TRIOXIDE INJ, 10 mg | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 112 ₹2.5 L | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 6.00 | AXITINIB TAB, 5 mg | 1 | 1 No | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78 ₹1.3 L | - | - | - | - | - | 2,042.86 ₹34.3 L | - | - | - | - | - | 44.1 ₹74,085 | - | 144 ₹2.4 L |
| 7.00 | AZACITIDINE INJ, 100 mg | 1 | Vial | - | 550 ₹92.4 L | 635 ₹1.1 Cr | 548 ₹92.1 L | - | 660 ₹1.1 Cr | - | - | - | - | - | - | - | - | - | - | - | - | 550 ₹92.4 L | 538 ₹90.4 L | 666 ₹1.1 Cr | 574 ₹96.4 L | - | - | - | - | - | - | - | - | - | - | - | - |
| 8.00 | AZACITIDINE TAB, 300 mg | 1 | 1 No | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 385 ₹86.2 L | - | - | - | - | - | - | - | - | - | - | - | - | - | 321.43 ₹72 L |
| 9.00 | BENDAMUSTINE INJ IP, 100mg | 1 | Vial | - | 550 ₹7.4 L | - | - | - | - | - | - | 1,520 ₹20.4 L | - | - | - | - | - | - | - | 565 ₹7.6 L | - | - | 648 ₹8.7 L | 548 ₹7.4 L | - | - | - | - | - | 540 ₹7.3 L | - | - | - | - | - | - | 702 ₹9.4 L |
| 10.00 | BEVACIZUMAB INJ., 100mg | 1 | Vial | - | - | 1,368 ₹1.4 Cr | 1,339 ₹1.4 Cr | - | 1,395 ₹1.5 Cr | - | - | - | - | - | - | - | 1,302 ₹1.4 Cr | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,895 ₹2.0 Cr | - |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
23 May 2025, 5:00 pmClosed
DIRECTOR
Regional Cancer Centre, Medical College PO, Thiruvananthapuram, Kerala, PIN-695011
Supply 187 Anti Cancer (Generic / Innovator on demand) Drugs on rate contract basis to Regional Cancer Centre,Thiruvananthapuram
2025_RCC_763290_1
03/RCC/2025-26/E9274/P2
Open Tender
Medicines
30 days
Regional Cancer Centre
Please refer Tender documents.
14 documents required · 14 mandatory
₹25,000
₹1 L
20 Dec 2025
5 May 2025
26 May 2025
5 May 2025
23 May 2025
6 May 2025
5 May 2025 - 23 May 2025
stage.html
html • 0.15 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid